Maternal and foetal outcomes in pregnant systemic lupus erythematosus patients: An incident cohort from a stable referral population followed during 1990-2010

Scandinavian Journal of Rheumatology

Volumn 44, Issue 5, 2015, Pages 377-384

  Jakobsen, I M ^a   Helmig, R B ^a   Stengaard Pedersen, K ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AZATHIOPRINE; CYCLOPHOSPHAMIDE; DEXAMETHASONE; HEPARIN; HYDROXYCHLOROQUINE; PHOSPHOLIPID ANTIBODY; PREDNISOLONE;

ADULT; ARTHRALGIA; ARTHRITIS; ARTICLE; BIRTH WEIGHT; CESAREAN SECTION; COHORT ANALYSIS; CONGENITAL HEART BLOCK; DISEASE ACTIVITY; DRUG MEGADOSE; FEMALE; FETUS OUTCOME; FOLLOW UP; GLOMERULONEPHRITIS; HEART SEPTUM DEFECT; HELLP SYNDROME; HEMATURIA; HUMAN; INTRAUTERINE GROWTH RETARDATION; LOW DRUG DOSE; LUPUS ERYTHEMATOSUS; MAJOR CLINICAL STUDY; MATERNAL HYPERTENSION; NEWBORN DEATH; PATIENT REFERRAL; PREECLAMPSIA; PREGNANCY OUTCOME; PREGNANT WOMAN; PREMATURE LABOR; PREMATURITY; PRIORITY JOURNAL; PROTEINURIA; SOLUTIO PLACENTAE; SPONTANEOUS ABORTION; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTOPENIA; UNIVERSITY HOSPITAL; VAGINAL DELIVERY; ABORTION, SPONTANEOUS; ADOLESCENT; COMPLICATION; DENMARK; FETAL GROWTH RETARDATION; HEART DEFECTS, CONGENITAL; INCIDENCE; LUPUS ERYTHEMATOSUS, SYSTEMIC; MATERNAL WELFARE; NEWBORN; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS; PREMATURE BIRTH; REGISTER; RETROSPECTIVE STUDY; RISK FACTOR; YOUNG ADULT;

ABORTION, SPONTANEOUS; ADOLESCENT; ADULT; COHORT STUDIES; DENMARK; FEMALE; FETAL GROWTH RETARDATION; HEART DEFECTS, CONGENITAL; HELLP SYNDROME; HUMANS; INCIDENCE; INFANT, NEWBORN; LUPUS ERYTHEMATOSUS, SYSTEMIC; MATERNAL HEALTH; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; PREMATURE BIRTH; REGISTRIES; RETROSPECTIVE STUDIES; RISK FACTORS; YOUNG ADULT;

EID: 84943272212     PISSN: 03009742     EISSN: 15027732     Source Type: Journal    
DOI: 10.3109/03009742.2015.1013982     Document Type: Article

References (42)

1. Meyer O. Making pregnancy safer for patients with lupus. Joint Bone Spine 2004; 71: 178-82.
2. Doria A, Tincani A, Lockshin M. Challenges of lupus pregnancies. Rheumatology (Oxford) 2008; 47 (Suppl 3): iii9-12.
3. Bramham K, Soh MC, Nelson-Piercy C. Pregnancy and renal outcomes in lupus nephritis: an update and guide to management. Lupus 2012; 21: 1271-83.
4. Ekblom-Kullberg S, Kautiainen H, Alha P, Helve T, Leirisalo-Repo M, Julkunen H. Reproductive health in women with systemic lupus erythematosus compared to population controls. Scand J Rheumatol 2009; 38: 375-80.
5. Ostensen M, Clowse M. Pathogenesis of pregnancy complications in systemic lupus erythematosus. Curr Opin Rheumatol 2013; 25: 591-6.
6. Petri M, Howard D, Repke J. Frequency of lupus flare in pregnancy. The Hopkins Lupus Pregnancy Center experience. Arthritis Rheum 1991; 34: 1538-45.
7. Le Huong D, Wechsler B, Vauthier-Brouzes D, Seebacher J, Lefebvre G, Bletry O, et al. Outcome of planned pregnancies in systemic lupus erythematosus: a prospective study on 62 pregnancies. Br J Rheumatol 1997; 36: 772-7.
8. Cortes-Hernandez J, Ordi-Ros J, Paredes F, Casellas M, Castillo F, Vilardell-Tarres M. Clinical predictors of fetal and maternal outcome in systemic lupus erythematosus: a prospective study of 103 pregnancies. Rheumatology (Oxford) 2002; 41: 643-50.
9. Petri M. Prospective study of systemic lupus erythematosus pregnancies. Lupus 2004; 13: 688-9.
10. Chakravarty EF, Colon I, Langen ES, Nix DA, El-Sayed YY, Genovese MC, et al. Factors that predict prematurity and preeclampsia in pregnancies that are complicated by systemic lupus erythematosus. Am J Obstet Gynecol 2005; 192: 1897-904.
11. Johns KR, Morand EF, Littlejohn GO. Pregnancy outcome in systemic lupus erythematosus (SLE): a review of 54 cases. Aust N Z J Med 1998; 28: 18-22.
12. Kwok LW, Tam LS, Zhu T, Leung YY, Li E. Predictors of maternal and fetal outcomes in pregnancies of patients with systemic lupus erythematosus. Lupus 2011; 20: 829-36.
13. Empson M, Lassere M, Craig J, Scott J. Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant. Cochrane Database Syst Rev 2005;(2): CD002859.
14. Lateef A, Petri M. Management of pregnancy in systemic lupus erythematosus. Nat Rev Rheumatol 2012; 8: 710-18.
15. Imbasciati E, Tincani A, Gregorini G, Doria A, Moroni G, Cabiddu G, et al. Pregnancy in women with pre-existing lupus nephritis: predictors of fetal and maternal outcome. Nephrol Dial Transplant 2009; 24: 519-25.
16. Clowse ME, Magder LS, Witter F, Petri M. The impact of increased lupus activity on obstetric outcomes. Arthritis Rheum 2005; 52: 514-21.
17. Rahman FZ, Rahman J, Al-Suleiman SA, Rahman MS. Pregnancy outcome in lupus nephropathy. Arch Gynecol Obstet 2005; 271: 222-6.
18. Brucato A, Frassi M, Franceschini F, Cimaz R, Faden D, Pisoni MP, et al. Risk of congenital complete heart block in newborns of mothers with anti-Ro/SSA antibodies detected by counterimmunoelectrophoresis: a prospective study of 100 women. Arthritis Rheum 2001; 44: 1832-5.
19. Julkunen H, Jouhikainen T, Kaaja R, Leirisalo-Repo M, Stephansson E, Palosuo T, et al. Fetal outcome in lupus pregnancy: a retrospective case-control study of 242 pregnancies in 112 patients. Lupus 1993; 2: 125-31.
20. American College of Rheumatology. The 1982 Revised Criteria for Classification of Systemic Lupus Erythematosus. Available at: www.rheumatology.org/practice/clinical/classification/SLE/sle.asp. Accessed 12 December 2012.
21. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40: 1725.
22. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-7.
23. Haram K, Svendsen E, Abildgaard U. The. HELLP syndrome: clinical issues and management. A review. BMC Pregnancy Childbirth 2009; 9: 8.
24. Cavallasca JA, Laborde HA, Ruda-Vega H, Nasswetter GG. Maternal and fetal outcomes of 72 pregnancies in Argentine patients with systemic lupus erythematosus (SLE). Clin Rheumatol 2008; 27: 41-6.
25. Clark CA, Spitzer KA, Nadler JN, Laskin CA. Preterm deliveries in women with systemic lupus erythematosus. J Rheumatol 2003; 30: 2127-32.
26. Carmona F, Font J, Cervera R, Munoz F, Cararach V, Balasch J. Obstetrical outcome of pregnancy in patients with systemic lupus erythematosus. A study of 60 cases. Eur J Obstet Gynecol Reprod Biol 1999; 83: 137-42.
27. Clowse ME, Jamison M, Myers E, James AH. A national study of the complications of lupus in pregnancy. Am J Obstet Gynecol 2008; 199: 127. e1-6.
28. Petri M, Allbritton J. Fetal outcome of lupus pregnancy: a retrospective case-control study of the Hopkins Lupus Cohort. J Rheumatol 1993; 20: 650-6.
29. Madazli R, Bulut B, Erenel H, Gezer A, Guralp O. Systemic lupus erythematosus and pregnancy. J Obstet Gynaecol 2010; 30: 17-20.
30. Huong DL, Wechsler B, Vauthier-Brouzes D, Beaufils H, Lefebvre G, Piette JC. Pregnancy in past or present lupus nephritis: a study of 32 pregnancies from a single centre. Ann Rheum Dis 2001; 60: 599-604.
31. Reinisch JM, Simon NG, Karow WG, Gandelman R. Prenatal exposure to prednisone in humans and animals retards intrauterine growth. Science 1978; 202: 436-8.
32. Tendron A, Gouyon JB, Decramer S. In utero exposure to immunosuppressive drugs: experimental and clinical studies. Pediatr Nephrol 2002; 17: 121-30.
33. Andrade R, Sanchez ML, Alarcon GS, Fessler BJ, Fernandez M, Bertoli AM, et al. Adverse pregnancy outcomes in women with systemic lupus erythematosus from a multiethnic US cohort: LUMINA (LVI) [corrected]. Clin Exp Rheumatol 2008; 26: 268-74.
34. Georgiou PE, Politi EN, Katsimbri P, Sakka V, Drosos AA. Outcome of lupus pregnancy: a controlled study. Rheumatology (Oxford) 2000; 39: 1014-19.
35. Buyon JP. Updates on lupus and pregnancy. Bull NYU Hosp Jt Dis 2009; 67: 271-5.
36. Declercq E, Young R, Cabral H, Ecker J. Is a rising cesarean delivery rate inevitable? Trends in industrialized countries, 1987 to 2007. Birth 2011; 38: 99-104.
37. Gibbons L, Belizan JM, Lauer JA, Betran AP, Merialdi M, Althabe F. Inequities in the use of cesarean section deliveries in the world. Am J Obstet Gynecol 2012; 206: 331. e1-19.
38. Lambers DS, Clark KE. The maternal and fetal physiologic effects of nicotine. Semin Perinatol 1996; 20: 115-26.
39. Castro LC, Allen R, Ogunyemi D, Roll K, Platt LD. Cigarette smoking during pregnancy: acute effects on uterine flow velocity waveforms. Obstet Gynecol 1993; 81: 551-5.
40. Aagaard-Tillery KM, Porter TF, Lane RH, Varner MW, Lacoursiere DY. In utero tobacco exposure is associated with modified effects of maternal factors on fetal growth. Am J Obstet Gynecol 2008; 198: 66. e1-6.
41. Roquer JM, Figueras J, Botet F, Jimenez R. Influence on fetal growth of exposure to tobacco smoke during pregnancy. Acta Paediatr 1995; 84: 118-21.
42. Vinet E, Scott S, Pineau CA, Clarke AE, Platt RW, Bernatsky S. Increased cardiac septal defects in children born to women with systemic lupus erythematosus: results from the OSLER study. Available at: ww2.rheumatology.org/apps/MyAnnualMeeting/Abstract/36261. Accessed 26 November 2013.